JW THERAP-B

02126

----

Current ValuationThe current P/E ratio is -3.13, below the reasonable range, cheaper than 83.67% of the time in the past 5 years, and the industry ranks 29/78, the industry Median -5.42.

-3.13xP/E

Stock priceHK$2.93Earnings per shareHK$-0.94

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0165330495660

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x40x80x120x160x200x

P/E ratio
Name/Symbol
09926HKAKESO	-91.49x	83.34%	HK$101.88B
09688HKZAI LAB	-16.04x	505.86%	HK$23.67B
07666HKMETIS TECHBIO-P	-51.43x	96.70%	HK$20.93B
01877HKJUNSHI BIO	-41.13x	84.85%	HK$19.03B
09606HKDUALITYBIO-B	-11.04x	85.58%	HK$18.28B
02595HKGENFLEET-B	-8.39x	78.96%	HK$12.71B
02627HKAB&B BIO-TECH-B	-46.87x	--	HK$11.54B
06855HKASCENTAGE	-6.80x	18.21%	HK$11.50B
01952HKEVEREST MED	-170.38x	324.61%	HK$10.58B
09887HKLEADS BIOLABS-B	-32.94x	8.67%	HK$10.12B
01672HKASCLETIS-B	-14.08x	78.59%	HK$9.59B
06938HKRIBOLIFE-B	-47.93x	29.88%	HK$9.36B
02616HKCSTONE PHARMA-B	-19.35x	1.72%	HK$9.34B
02493HKMABWELL-B	-8.40x	--	HK$9.09B
09966HKALPHAMAB-B	-39.98x	--	HK$8.10B
01779HKLONGBIO-B	-31.12x	--	HK$7.75B
02171HKCARSGEN-B	-75.23x	51.12%	HK$7.73B
02335HKMICOT PHARMA-B	-17.95x	37.50%	HK$7.53B
02256HKABBISKO-B	-11.87x	300.95%	HK$6.38B
06872HKTENNOR THERAP-B	-36.86x	--	HK$5.91B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.